Bristol-Myers Changes CEO Comp Procedure

I've been thinking about CEO compensation as I'm writing a piece for Corporate Secretary on the topic. So I found the following story interesting: Bristol-Myers has taken a Harvard B-school professor's suggestion to make changes in CEO comp dependent on a vote of three-quarters of the company's board instead of a simple majority. In the wake of payouts at Home Depot and the NYSE, and the hail of criticism that followed, directors appear ready to change business as usual.